Vaxart, Inc. (VXRT)
0.5747
-0.02
(-2.58%)
USD |
OTCM |
Feb 11, 15:56
Vaxart Shareholders Equity (Quarterly) : 26.76M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Bionano Genomics, Inc. | 49.80M |
| Agenus, Inc. | -274.14M |
| Curis, Inc. | -14.69M |
| LadRx Corp. | -2.135M |
| Plus Therapeutics, Inc. | 5.054M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 208.99M |
| Total Liabilities (Quarterly) | 182.23M |
| Debt to Equity Ratio | 0.7086 |
| Current Ratio | 0.6933 |
| Net Debt Paydown Yield | 1.00% |